Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol[S]
暂无分享,去创建一个
Perttu S. Niemelä | M. Taskinen | M. Orešič | I. Vattulainen | M. Hyvönen | M. Jauhiainen | L. Yetukuri | T. Seppänen-Laakso | A. Koivuniemi | S. Söderlund | Sanni Söderlund
[1] P. Whincup,et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. , 2009, Atherosclerosis.
[2] P. Barter,et al. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[3] M. Taskinen,et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations , 2009, Diabetologia.
[4] Matej Oresic,et al. Lipidomics: a new window to biomedical frontiers. , 2008, Trends in biotechnology.
[5] J. Kumpula,et al. Reconsideration of hydrophobic lipid distributions in lipoprotein particles. , 2008, Chemistry and physics of lipids.
[6] G. Watts,et al. HDL metabolism in context: looking on the bright side , 2008, Current opinion in lipidology.
[7] J. Heinecke,et al. The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. , 2008, Biochemistry.
[8] R. Larson,et al. The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.
[9] Perttu S. Niemelä,et al. Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations. , 2008, Biophysical journal.
[10] D. van der Spoel,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[11] J. Kastelein,et al. High-density lipoprotein: A fall from grace? , 2008, Annals of medicine.
[12] D. Tieleman,et al. The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.
[13] Sina A. Gharib,et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.
[14] Marko Sysi-Aho,et al. Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.
[15] D. Rader. Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.
[16] P. Subbaiah,et al. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate. , 2006, Biochemistry.
[17] M. Taskinen,et al. Decreased High-Density Lipoprotein (HDL) Particle Size, Pre&bgr;-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[18] M. Jauhiainen,et al. Determination of human plasma phospholipid transfer protein mass and activity. , 2005, Methods.
[19] Xianlin Han,et al. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.
[20] C. Fielding,et al. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. , 2004, Biochemistry.
[21] R. Murphy,et al. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids , 2004, Journal of the American Society for Mass Spectrometry.
[22] A. Tall,et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] H. Brewer,et al. Increasing HDL Cholesterol Levels. , 2004, The New England journal of medicine.
[24] M. Jauhiainen,et al. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA Published, JLR Papers in Press, November 16, 2003. DOI 10.1194/jlr.D300023-JLR200 , 2004, Journal of Lipid Research.
[25] M. Jauhiainen,et al. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M300059-JLR200 , 2003, Journal of Lipid Research.
[26] I. Jolliffe,et al. Principal Component Analysis , 2003, Encyclopedia of Machine Learning.
[27] M. Phillips,et al. High density lipoprotein structure. , 2003, Frontiers in bioscience : a journal and virtual library.
[28] M. Barker,et al. Partial least squares for discrimination , 2003 .
[29] A. Colell,et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. , 2003, The Journal of clinical investigation.
[30] R. Maeba,et al. Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200340-JLR200 , 2003, Journal of Lipid Research.
[31] D. Vance,et al. Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .
[32] P. Barter,et al. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. , 2002, Atherosclerosis. Supplements.
[33] Y. Marcel,et al. Heteronuclear NMR studies of human serum apolipoprotein A‐I , 2002, FEBS letters.
[34] J. Viikari,et al. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. , 2002, Journal of lipid research.
[35] M. Jauhiainen,et al. Dietary determinants of serum paraoxonase activity in healthy humans. , 2002, Atherosclerosis.
[36] R. Murphy. Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. , 2001, Chemical research in toxicology.
[37] M. Jauhiainen,et al. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. , 2001, Atherosclerosis.
[38] A. Jonas,et al. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. , 2001, Journal of lipid research.
[39] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[40] W. J. Johnson,et al. High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI* , 2000, The Journal of Biological Chemistry.
[41] K. Rye,et al. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. , 2000, Biochemistry.
[42] Anthony E. Klon,et al. A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein* , 1999, The Journal of Biological Chemistry.
[43] H. Brewer,et al. Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[45] A. Chapelle,et al. The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein , 1999, Nature Medicine.
[46] G. Lewis,et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. , 1999, The Journal of clinical investigation.
[47] A. Tall,et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.
[48] J. Gamble,et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Parks,et al. The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation* , 1998, The Journal of Biological Chemistry.
[50] P. Barter,et al. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. , 1998, Journal of lipid research.
[51] J. Engler,et al. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Paul,et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[53] H. Brewer,et al. Plasma Phospholipid Transfer Protein , 1997, The Journal of Biological Chemistry.
[54] J. Breslow,et al. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[55] A. Tall,et al. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. , 1996, The Journal of clinical investigation.
[56] A. Jonas,et al. Sphingomyelin Inhibits the Lecithin-Cholesterol Acyltransferase Reaction with Reconstituted High Density Lipoproteins by Decreasing Enzyme Binding* , 1996, The Journal of Biological Chemistry.
[57] W. J. Johnson,et al. The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.
[58] M. Krönke,et al. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown , 1992, Cell.
[59] N. Maeda,et al. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Ibdah,et al. Effects of lipid composition and packing on the adsorption of apolipoprotein A-I to lipid monolayers. , 1988, Biochemistry.
[61] M. Taskinen,et al. Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.
[62] J. Groener,et al. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. , 1986, Clinical chemistry.
[63] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[64] G. Scherphof,et al. Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. , 1982, Biochimica et biophysica acta.
[65] E. Gong,et al. Characterization of human high-density lipoproteins by gradient gel electrophoresis. , 1981, Biochimica et biophysica acta.
[66] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[67] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[68] Seppo Koskinen,et al. HEALTH AND FUNCTIONAL CAPACITY IN FINLAND Baseline Results of the Health 2000 Health Examination Survey , 2004 .
[69] C. Couillard,et al. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. , 2001, Journal of lipid research.
[70] B. Kowalski,et al. Partial least-squares regression: a tutorial , 1986 .
[71] W. H. Heaton,et al. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. , 1982, Arteriosclerosis.